0001209191-18-045833.txt : 20180808
0001209191-18-045833.hdr.sgml : 20180808
20180808162843
ACCESSION NUMBER: 0001209191-18-045833
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180806
FILED AS OF DATE: 20180808
DATE AS OF CHANGE: 20180808
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GRAHAM GINGER L
CENTRAL INDEX KEY: 0001192601
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51541
FILM NUMBER: 181001766
MAIL ADDRESS:
STREET 1: AMYLIN PHARMACEUTICALS, INC.
STREET 2: 885 ARAPAHOE AVENUE
CITY: BOULDER
STATE: CO
ZIP: 80302
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GENOMIC HEALTH INC
CENTRAL INDEX KEY: 0001131324
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 770552594
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-556-9300
MAIL ADDRESS:
STREET 1: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-08-06
0
0001131324
GENOMIC HEALTH INC
GHDX
0001192601
GRAHAM GINGER L
1108 NORTH LEMAY AVENUE
FORT COLLINS
CO
80524
1
0
0
0
Common Stock
2018-08-06
4
M
0
16500
17.33
A
26756
I
Held by the GInger L. Graham Revocable Trust
Director Stock Option (right to buy)
17.33
2018-08-06
4
M
0
16500
0.00
D
2018-12-04
Common Stock
16500
0
D
The option became exercisable as to 25% of the shares on December 4, 2009, and became exercisable as to 1/48th of the shares each full month thereafter.
/s/ Jason W. Radford, Attorney-in-fact
2018-08-08